EP3380486
Forlyf JAK hindra til mehöndlunar á bólgusjúkdómi í meltingarvegi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
22.11.2016EP published:
19.2.2020EP application number:
16808876.3
EP translation filed:
16.4.2020Grant published:
15.5.2020EPO information:
European Patent Register
Max expiry date:
21.11.2036Expiry date:
21.11.2022
Title:
PRODRUGS OF A JAK INHIBITOR COMPOUND FOR TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISEASE
Timeline
Today
22.11.2016EP application
19.2.2020EP Publication
16.4.2020Translation submitted
15.5.2020Registration published
21.11.2022Expires
Owner
Name:
Theravance Biopharma R&D IP, LLCAddress:
901 Gateway Boulevard, South San Francisco, CA 94080, US
Inventor
Name:
HUDSON, RyanAddress:
San Jose, California 95129, US
Name:
LONG, Daniel D.Address:
San Francisco, California 94131, US
Name:
WILTON, Donna A.A.Address:
San Francisco, California 94110, US
Name:
LOO, MandyAddress:
San Jose, California 95131, US
Name:
BRASSIL, Patrick J.Address:
California, CA 94061, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562259273 PDate:
24.11.2015Country:
US
Classification
Categories:
C07H 15/26, C07D 487/04, A61K 31/7052, A61P 1/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 2.11.2020
Expires: 21.11.2021
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 2.11.2021
Expires: 21.11.2022
Payer: Sigurjónsson & Thor ehf.